Market revenue in 2023 | USD 7,065.1 million |
Market revenue in 2030 | USD 11,684.2 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 72.25% in 2023. Horizon Databook has segmented the Asia Pacific high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific consists of a blend of developing and developed economies. Rising healthcare expenditure in the region is anticipated to fuel the market growth. According to NCBI, in 2019, 24% of overall breast cancer cases are in Japan, China, and Indonesia in Asia Pacific region. However, increasing access to oncology diagnosis and treatment is anticipated to fuel the growth of the market.
Asia Pacific market for HPAPI is expected to show significant growth over the forecast period, which can be attributed to presence of emerging economies, rapidly growing oncology market, supportive government initiatives, and growing investments in biotechnology sector.
In addition, growing generics sector and improving healthcare facilities are anticipated to fuel the market growth in the near future.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific high potency active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account